Gordon, Leo I. External Author

Publications

Sort by

Selected publications

  • Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphomaJournal of Clinical Oncology2005 Academic Article GET IT
    Times cited: 133